Oppenheimer Reiterates Oracle (ORCL) at Perform 'due to valuation as ORCL shares trade at a material premium to peers'

Bernstein SocGen Group Reiterates Outperform Rating on Oracle (ORCL)

Bernstein SocGen Group analyst Mark Moerdler reiterated an Outperform rating and $175.00 price target on Oracle (NYSE: ORCL)

The analyst comments "With everything going on at Oracle we felt it was important to spend more than just the Financial Analyst Day at the Oracle Cloud... More

Citi Reiterates Neutral Rating on Oracle (ORCL)

Citi analyst Tyler Radke reiterated a Neutral rating and $157.00 price target on Oracle (NYSE: ORCL)

The analyst comments "Ahead of ORCLs 9/12 financial analyst day, we spent the day attending the Cloud World Conference in Las Vegas, speaking to a dozen partners and... More

Oracle (ORCL) PT Raised to $176 at Argus, Remains on Focus List

Argus raised its price target on Oracle (NYSE: ORCL) to $176.00 (from $159.00) while maintaining a Buy rating.

The analyst comments "We reiterating our BUY rating on Focus List selection Oracle Corp. (NGS: ORCL) and raising our target price to $176 from $159. Oracle is in the enviable position of having... More

CFRA Reiterates Hold Rating on Oracle (ORCL), PT $150

CFRA analyst Angelo Zino reiterated a Hold rating and $150.00 price target on Oracle (NYSE: ORCL).

The analyst comments "We hold our 12-month target at $150, on a P/E of 22x our CY 25 EPS estimate of $6.80, above historical/below peers. We keep our FY 25... More

William Blair Reiterates Outperform Rating on Oracle (ORCL)

William Blair analyst Sebastien Naji reiterated an Outperform rating on Oracle (NYSE: ORCL)

The analyst comments "Stock Thoughts: At an after-hours price of $152 per share (up 9% after-hours), Oracle trades at a price-to-earnings multiple of 22 times our calendar 2025 estimate. In our view, Oracle is... More

Melius Reiterates Hold Rating on Oracle (ORCL), 'One of the Better Beats in Software of Late'

Melius analyst Ben Reitzes reiterated a Hold rating and $155.00 price target on Oracle (NYSE: ORCL).

The analyst comments "

An Increasingly Credible Case into Analyst Meeting: So last quarter was an RPO (remaining performance obligations) beat, but a miss on everything else and the... More